Filing Details
- Accession Number:
- 0001179110-17-002953
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-22 17:59:59
- Reporting Period:
- 2017-02-17
- Filing Date:
- 2017-02-22
- Accepted Time:
- 2017-02-22 17:59:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1635313 | Roger Bird | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2017-02-17 | 13,307 | $0.00 | 63,910 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 727 | $44.69 | 63,183 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 219 | $44.91 | 62,964 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 100 | $45.00 | 62,864 | No | 4 | S | Direct | |
Common Shares Without Par Value | Acquisiton | 2017-02-22 | 11,030 | $26.70 | 73,894 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2017-02-22 | 1,873 | $26.20 | 75,767 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-22 | 9,936 | $45.02 | 65,831 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-22 | 700 | $45.03 | 65,131 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-22 | 100 | $45.03 | 65,031 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-22 | 1,500 | $45.04 | 63,531 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-22 | 400 | $45.04 | 63,131 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-22 | 100 | $45.04 | 63,031 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-22 | 167 | $45.05 | 62,864 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2017-02-17 | 92,032 | $0.00 | 92,032 | $44.40 |
Common Shares | Option (right to buy) | Disposition | 2017-02-22 | 11,030 | $0.00 | 11,030 | $26.70 |
Common Shares | Option (right to buy) | Disposition | 2017-02-22 | 1,873 | $0.00 | 1,873 | $26.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
92,032 | 2018-02-17 | 2027-02-16 | No | 4 | A | Direct |
0 | 2011-02-15 | 2018-02-14 | No | 4 | M | Direct |
0 | 2011-03-31 | 2018-03-30 | No | 4 | M | Direct |
Footnotes
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,678 on 02/17/2018, 30,677 on 02/17/2019, and 30,677 on 02/17/2020.
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.